This report contains market size and forecasts of Paclitaxel and Its Analogue in Anticarcinoma Drugs in Global, including the following market information:
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Paclitaxel and Its Analogue in Anticarcinoma Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Paclitaxel Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Paclitaxel and Its Analogue in Anticarcinoma Drugs include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare and Beijing Union, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paclitaxel and Its Analogue in Anticarcinoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Segment Percentages, by Type, 2021 (%)
Paclitaxel
Docetaxel
Liposome Paclitaxel
Protein-bound Paclitaxel
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Segment Percentages, by Application, 2021 (%)
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Non-small Cell Lung Cancer
Other
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paclitaxel and Its Analogue in Anticarcinoma Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Paclitaxel and Its Analogue in Anticarcinoma Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
CSPC Pharmaceutical
Aosaikang Pharm